A. Rapoport

Treatment of multifocal lymphoma of bone with intensified Promace‐Cytabom chemotherapy and involved field radiotherapy

L. Constine, R. O’Keefe, David G. Hicks, 1998, American journal of hematology.

Autotransplantation for relapsed or refractory Hodgkin’s disease: long-term follow-up and analysis of prognostic factors

R. Brasacchio, A. Muhs, S. Eberly, 1998, Bone Marrow Transplantation.

Continuous infusion cyclosporine and nifedipine to day +100 with short methotrexate and steroids as GVHD prophylaxis in unrelated donor transplants

J. Rowe, C. Packman, J. DiPersio, 1999, Bone Marrow Transplantation.

Analysis of factors that correlate with mucositis in recipients of autologous and allogeneic stem-cell transplants.

L. Constine, J. Liesveld, C. Abboud, 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

One hundred autotransplants for relapsed or refractory Hodgkin's disease and lymphoma: value of pretransplant disease status for predicting outcome.

M. A. Tanner, J. Liesveld, C. Abboud, 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Major clinical response to nivolumab in relapsed/refractory Hodgkin lymphoma after allogeneic stem cell transplantation

E. Sausville, A. Rapoport, Z. Singh, 2016, Bone Marrow Transplantation.

Treatment of chronic myelogenous leukemia with autologous bone marrow transplantation followed by roquinimex

B. Simonsson, J. Rowe, C. Packman, 1999, Bone Marrow Transplantation.

Autotransplantation for advanced lymphoma and Hodgkin's disease followed by post-transplant rituxan/GM-CSF or radiotherapy and consolidation chemotherapy

G. Tricot, R. Fenton, B. Mookerjee, 2002, Bone Marrow Transplantation.

Autotransplantation for relapsed or refractory non-Hodgkin’s lymphoma (NHL): long-term follow-up and analysis of prognostic factors

R. Lifton, S. Eberly, J. Rowe, 1997, Bone Marrow Transplantation.

Patients > or = age 40 years undergoing autologous or allogeneic BMT have regimen-related mortality rates and event-free survivals comparable to patients < age 40 years.

J. Dipersio, M. A. Tanner, L. Constine, 1995, Bone marrow transplantation.